Coloplast A/S
OTC:CLPBF

Watchlist Manager
Coloplast A/S Logo
Coloplast A/S
OTC:CLPBF
Watchlist
Price: 82.05 USD -8.65% Market Closed
Market Cap: 18.4B USD

Operating Margin

27.5%
Current
Declining
by 0.2%
vs 3-y average of 27.8%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
27.5%
=
Operating Income
kr7.7B
/
Revenue
kr27.9B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
27.5%
=
Operating Income
$7.7B
/
Revenue
kr27.9B

Peer Comparison

Country Company Market Cap Operating
Margin
DK
Coloplast A/S
CSE:COLO B
121.4B DKK
Loading...
JP
Hoya Corp
TSE:7741
8.5T JPY
Loading...
CH
Alcon AG
SIX:ALC
30.9B CHF
Loading...
US
Medline Inc
NASDAQ:MDLN
35.8B USD
Loading...
US
Align Technology Inc
NASDAQ:ALGN
11.9B USD
Loading...
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
44.9B CNY
Loading...
UK
ConvaTec Group PLC
LSE:CTEC
4.7B GBP
Loading...
CA
Bausch + Lomb Corp
NYSE:BLCO
6.1B USD
Loading...
CH
Ypsomed Holding AG
SIX:YPSN
4.5B CHF
Loading...
US
Merit Medical Systems Inc
NASDAQ:MMSI
4.8B USD
Loading...
JP
Asahi Intecc Co Ltd
TSE:7747
761B JPY
Loading...
No Stocks Found

Market Distribution

Higher than 83% of companies in Denmark
Percentile
83nd
Based on 506 companies
83nd percentile
27.5%
Low
-5 981.6% — 1.3%
Typical Range
1.3% — 16.3%
High
16.3% — 423.3%
Distribution Statistics
Denmark
Min -5 981.6%
30th Percentile 1.3%
Median 7.5%
70th Percentile 16.3%
Max 423.3%

Coloplast A/S
Glance View

Coloplast A/S, headquartered in Humlebæk, Denmark, has a storied history that dates back to 1954 when a nurse, Elise Sørensen, identified a crucial need in the healthcare sector. Her sister had undergone ostomy surgery, and the lack of appropriate post-operative care products inspired Sørensen to design the world’s first adhesive ostomy bag. This innovation laid the groundwork for Coloplast's trajectory in the healthcare industry. Today, the company has expanded its focus to include ostomy care, continence care, wound and skin care, and interventional urology. With a commitment to improving patients' quality of life, Coloplast has become a leader in designing and manufacturing products that not only highlight practicality but also embody comfort and discretion. Coloplast generates revenue through a business model that emphasizes product innovation and direct engagement with healthcare providers and patients. The company invests significantly in research and development to improve and widen its product offerings continuously. It operates globally, distributing its products directly and via partnerships with hospitals, clinics, and healthcare professionals. By maintaining an attentive approach to user experience and incorporating customer feedback into its development processes, Coloplast ensures its portfolio aligns with the actual needs of its users. This user-centered strategy not only enhances customer loyalty but also fortifies the company’s market position, driving its financial success.

CLPBF Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
27.5%
=
Operating Income
kr7.7B
/
Revenue
kr27.9B
What is Coloplast A/S's current Operating Margin?

The current Operating Margin for Coloplast A/S is 27.5%, which is below its 3-year median of 27.8%.

How has Operating Margin changed over time?

Over the last 3 years, Coloplast A/S’s Operating Margin has decreased from 30.6% to 27.5%. During this period, it reached a low of 26.9% on Dec 31, 2024 and a high of 30.6% on Sep 30, 2022.

Back to Top